Syed A. Abutalib,MD


Associate Medical Director, Hematologic Malignancies and Stem Cell Transplant Program, City of Hope Chicago

Syed A. Abutalib - Assistant Director, Stem Cell Transplant & Cell Therapy Program, Hematologist & Medical Oncologist

I listen to patients and their families to address their specific concerns, and I work in harmony with the hospital’s multidisciplinary clinicians to provide an integrative care plan that is both understandable and agreed upon by each patient and his or her family.

CTCA Chicago
2520 Elisha Avenue
Zion, Illinois 60099
Hematologic Oncology
Medical school:

Dow University of Health Sciences (Dow Medical College), Karachi, Pakistan


Internal Medicine/Surgery – Dow Medical College/Civil Hospital, Karachi, Pakistan
Internal Medicine - Cook County Hospital (John H. Stroger Jr. Hospital of Cook County), Chicago, IL

Hematology & Oncology - University of Illinois College of Medicine, Chicago
Hematology & Oncology - American Board of Internal Medicine

Dr. Syed Abutalib, who joined City of Hope Chicago, in 2008, places the care for his patients and their families first and foremost. He believes in creating an atmosphere that facilitates open, honest, three-way patient, caregiver and doctor communication, which is why he is always accessible to his patients and their families. Dr. Abutalib’s care reaches far beyond the walls of our Chicago-area hospital, as he routinely provides patients and family members with his cellphone number to call should they ever need to consult with him. The board-certified hematologic oncologist devotes ample time to each of his patients, empowering them to take an active role in their treatment plan.

Dr. Abutalib earned a medical degree from Dow Medical College in Karachi, Pakistan. He completed an internal medicine residency with an emphasis in hematologic malignancies at Cook County Hospital in Chicago. He completed a fellowship in hematology/oncology at the University of Illinois at Chicago (UIC), with an emphasis on blood and bone marrow transplantation. During the same period of time, he was granted permission to pursue his interest in research at Robert H. Lurie Comprehensive Cancer Center of Northwestern University, working with Martin S. Tallman, and at The University of Chicago Medicine Comprehensive Cancer Center, working with Dr. Wendy Stock. While working on his fellowship, Dr. Abutalib voluntarily spearheaded the Thrombosis and Homeostasis conference at UIC, in addition to a variety of other educational projects.

Dr. Abutalib has co-edited many hematology and bone marrow transplant books and has been published in a number of medical journals and textbooks. Dr. Abutalib is the associate editor for the American Society of Clinical Oncology (ASCO) magazine, The ASCO Post. He is also the reviewer for the journal Blood Reviews and the update editor for one of the leading textbooks, Hematology, Basic Principles and Practice (7th edition) by Hoffman. Additionally, he has presented at clinical conferences and meetings on a variety of topics related to hematologic disease, including the Chicago Lymphoma Society.

Dr. Abutalib is an associate professor at Rosalind Franklin University of Medicine and Science, where he is involved in educating and mentoring medical students, and is an active member of the American Society of Hematology (ASH), ASCO and the American Society of Blood and Marrow Transplant (ASBMT™). He also serves on the Executive Committee for Education for American Society of Transplantation & Cellular Therapy and is the Vice Chair on the Steering Committee for the International Initiative on Thrombosis and Cancer-Continuing Medical Education (ITAC-CME), and he continues to collaborate with other experts in the area of hematology/oncology to explore new medical breakthroughs and treatment options in order to better educate, treat and care for his patients.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.